Status:
UNKNOWN
Real-time Cancer Pain Assessment and Intervention
Lead Sponsor:
Sun Yat-sen University
Conditions:
Malignancy
Pain
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
This study aim at the advanced malignant tumor patients who suffer from cancer pain, investigate the current status of cancer pain treatment, and study the effects in pain control and quality of life ...
Detailed Description
1. Cancer pain is a common symptom exists in malignant tumor patients, which bother the patients and decrease the quality of life. 2. The goal of the study is that using the real-time monitoring and i...
Eligibility Criteria
Inclusion
- Solid tumors confirmed by pathology or cytology
- Eastern Cooperative Oncology Group Performance Status: 0-2
- sign the informed consent form
- good compliance, willing to comply with the requirements of the study
- anticipate survival time more than 3 months
- pain intensity is greater than 2 points according to numerical rating scale on enrollment; have indication of opioid analgesic drugs.
- can express subjective feelings of pain intensity clearly.
- own a smartphone or tablet device which can install and use the application program software, and can operate the software proficiently.
Exclusion
- poor compliance, refuse to sign the informed consent form, or difficult to comply with the requirement of the study.
- slight pain or no pain, no indication of opioid analgesic drugs.
- contraindication of opioid analgesic drugs
- no other medical workers give instructions during the study.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01914107
Start Date
March 1 2012
End Date
June 1 2018
Last Update
August 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510060